Literature DB >> 18321207

Alterations of porin, pumps, and penicillin-binding proteins in carbapenem resistant clinical isolates of Pseudomonas aeruginosa.

Christian G Giske1, Liselotte Buarø, Arnfinn Sundsfjord, Bengt Wretlind.   

Abstract

Carbapenem-resistant clinical isolates of Pseudomonas aeruginosa from Sweden and Norway (n=27) were characterized regarding transcription of genes encoding OprD, efflux pumps MexAB-OprM and MexCD-OprJ, as well as penicillin-binding proteins (PBP) 2 and 3. Quantification of mRNA was performed with real-time RT-PCR. Levels of mRNA in clinical isolates were compared to ATCC 27853 and average transcription levels of four carbapenem-susceptible clinical isolates of P. aeruginosa. Sequencing of oprD, pbp 2, and pbp 3 was performed in selected isolates. An efflux inhibition assay was performed with Phe-Arg-beta-naphtylamide. Most carbapenem-resistant isolates had decreased levels of oprD mRNA. Among six isolates with normal amount of oprD mRNA, half of them had significant OprD sequence alterations. Increased transcription of mexB was observed in 16 of 23 meropenem-resistant isolates, and one isolate showed mexD hyperproduction. Decreased amount of pbp 2 and pbp 3 was found in two and three isolates, respectively. Sequencing of pbp 2 and 3 revealed no amino acid changes potentially leading to conformational changes. In conclusion, OprD changes were the predominant mechanism of high-level carbapenem resistance, and increased transcription of mexB was often present in meropenem-resistant isolates. Reduced transcription of pbp 2 and 3 may contribute to the carbapenem resistance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18321207     DOI: 10.1089/mdr.2008.0778

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  11 in total

1.  Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.

Authors:  Bartolomé Moyá; Alejandro Beceiro; Gabriel Cabot; Carlos Juan; Laura Zamorano; Sebastián Alberti; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2012-06-25       Impact factor: 5.191

2.  The effects of active efflux pumps on antibiotic resistance in Pseudomonas aeruginosa.

Authors:  Huseyin Agah Terzi; Canan Kulah; Ihsan Hakkı Ciftci
Journal:  World J Microbiol Biotechnol       Date:  2014-06-26       Impact factor: 3.312

3.  Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study.

Authors:  Gabriel Cabot; Alain A Ocampo-Sosa; Fe Tubau; María D Macia; Cristina Rodríguez; Bartolomé Moya; Laura Zamorano; Cristina Suárez; Carmen Peña; Luis Martínez-Martínez; Antonio Oliver
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

Review 4.  Carbapenems: past, present, and future.

Authors:  Krisztina M Papp-Wallace; Andrea Endimiani; Magdalena A Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2011-08-22       Impact factor: 5.191

5.  Imipenem/Relebactam Resistance in Clinical Isolates of Extensively Drug Resistant Pseudomonas aeruginosa: Inhibitor-Resistant β-Lactamases and Their Increasing Importance.

Authors:  Andrea M Hujer; Christopher R Bethel; Magdalena A Taracila; Steven H Marshall; Laura J Rojas; Marisa L Winkler; Ronald E Painter; T Nicholas Domitrovic; Richard R Watkins; Ayman M Abdelhamed; Roshan D'Souza; Andrew R Mack; Richard C White; Thomas Clarke; Derrick E Fouts; Michael R Jacobs; Katherine Young; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2022-04-18       Impact factor: 5.938

6.  Molecular epidemiology of metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates from Norway and Sweden shows import of international clones and local clonal expansion.

Authors:  Orjan Samuelsen; Mark A Toleman; Arnfinn Sundsfjord; Johan Rydberg; Truls M Leegaard; Mats Walder; Astrid Lia; Trond E Ranheim; Yashas Rajendra; Nils O Hermansen; Timothy R Walsh; Christian G Giske
Journal:  Antimicrob Agents Chemother       Date:  2009-11-02       Impact factor: 5.191

7.  Stability, compatibility and microbiological activity studies of meropenem-clavulanate potassium.

Authors:  Judyta Cielecka-Piontek; Daria Szymanowska-Powałowska; Magdalena Paczkowska; Piotr Łysakowski; Przemysław Zalewski; Piotr Garbacki
Journal:  J Antibiot (Tokyo)       Date:  2014-07-30       Impact factor: 2.649

8.  Evaluation of multidrug efflux pump inhibitors by a new method using microfluidic channels.

Authors:  Yoshimi Matsumoto; Kohei Hayama; Shouichi Sakakihara; Kunihiko Nishino; Hiroyuki Noji; Ryota Iino; Akihito Yamaguchi
Journal:  PLoS One       Date:  2011-04-12       Impact factor: 3.240

9.  A microfluidic device for simple and rapid evaluation of multidrug efflux pump inhibitors.

Authors:  Ryota Iino; Kunihiko Nishino; Hiroyuki Noji; Akihito Yamaguchi; Yoshimi Matsumoto
Journal:  Front Microbiol       Date:  2012-02-08       Impact factor: 5.640

10.  A Microfluidic Channel Method for Rapid Drug-Susceptibility Testing of Pseudomonas aeruginosa.

Authors:  Yoshimi Matsumoto; Shouichi Sakakihara; Andrey Grushnikov; Kazuma Kikuchi; Hiroyuki Noji; Akihito Yamaguchi; Ryota Iino; Yasushi Yagi; Kunihiko Nishino
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.